{"title_page": "PX-1", "text_new": "{{Drugbox\n| IUPAC_name = (''S'')-''N''-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1''H''-indole-3-carboxamide\n| image = PX-1_structure.png\n\n<!--Clinical data-->\n| tradename =  \n| pregnancy_AU = \n| pregnancy_US = \n| pregnancy_category =  \n| legal_AU = \n| legal_CA = Schedule II\n| legal_DE = NpSG\n| legal_UK = PSA\n| legal_US = \n| legal_status = \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|CAS}}\n| CAS_number = 2221100-71-4\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII =  BJ7SBQ2H5I\n| ATC_prefix =  \n| ATC_suffix =  \n| PubChem = 125181260\n| ChemSpiderID      = 32055575\n| smiles            = O=C(N[C@H](C(N)=O)CC1=CC=CC=C1)C2=CN(CCCCCF)C3=C2C=CC=C3\n| StdInChI          = 1S/C23H26FN3O2/c24-13-7-2-8-14-27-16-19(18-11-5-6-12-21(18)27)23(29)26-20(22(25)28)15-17-9-3-1-4-10-17/h1,3-6,9-12,16,20H,2,7-8,13-15H2,(H2,25,28)(H,26,29)/t20-/m0/s1\n| StdInChIKey       = DDVANTXQCRMRFF-FQEVSTJZSA-N\n\n<!--Chemical data-->\n| C=23 | H=26 | N=3 | O=2 | F=1 \n| molecular_weight = \n}}\n\n'''PX-1''' (also known as '''5F-APP-PICA''' and '''SRF-30''') is an [[indole]]-based [[synthetic cannabinoid]] that has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/product/16201 | title=PX 1 | publisher=Cayman Chemical | access-date=15 July 2015}}</ref><ref>{{cite journal | vauthors = Presley BC, Logan BK, Jansen-Varnum SA | title = Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS | journal = Biomedical Chromatography | pages = e4786 | date = December 2019 | pmid = 31863591 | doi = 10.1002/bmc.4786 }}</ref>\n\n==Legality==\nSweden's public health agency suggested classifying PX-1 as hazardous substance on November 10, 2014.<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider f\u00f6resl\u00e5s bli klassade som h\u00e4lsofarlig vara | publisher=Folkh\u00e4lsomyndigheten | lang=sv | access-date=16 July 2015}}</ref>\n\nPX-1 is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.<ref>{{cite web | url=https://sso.agc.gov.sg/Act/MDA1973 | title=Misuse of Drugs Act | publisher=Singapore Government | date=30 April 2015 | access-date=24 July 2015}}</ref>\n\n== See also ==\n{{div col|colwidth=30em}}\n* [[5F-AB-PINACA]]\n* [[5F-ADB]]\n* [[5F-AMB]]\n* [[5F-APINACA]]\n* [[AB-FUBINACA]]\n* [[AB-CHFUPYCA]]\n* [[AB-CHMINACA]]\n* [[AB-PINACA]]\n* [[ADB-CHMINACA]]\n* [[ADB-FUBINACA]]\n* [[ADB-PINACA]]\n* [[ADBICA]]\n* [[APICA (synthetic cannabinoid drug)|APICA]]\n* [[APINACA]]\n* [[MDMB-CHMICA]]\n* [[PX-2]]\n* [[PX-3]]\n{{Div col end}}\n\n== References ==\n{{Reflist}}\n\n{{Cannabinoids}}\n{{Cannabinoidergics}}\n\n[[Category:Indoles]]\n[[Category:Cannabinoids]]\n[[Category:Designer drugs]]\n[[Category:Indolecarboxamides]]\n[[Category:Organofluorides]]\n\n{{cannabinoid-stub}}\n", "text_old": "{{Drugbox\n| IUPAC_name = (''S'')-''N''-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1''H''-indole-3-carboxamide\n| image = PX-1_structure.png\n\n<!--Clinical data-->\n| tradename =  \n| pregnancy_AU = \n| pregnancy_US = \n| pregnancy_category =  \n| legal_AU = \n| legal_CA = Schedule II\n| legal_DE = NpSG\n| legal_UK = PSA\n| legal_US = \n| legal_status = \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = \n| CAS_number = \n| ATC_prefix =  \n| ATC_suffix =  \n| PubChem = 125181260\n| ChemSpiderID      = 32055575\n| UNII = BJ7SBQ2H5I\n| smiles            = O=C(N[C@H](C(N)=O)CC1=CC=CC=C1)C2=CN(CCCCCF)C3=C2C=CC=C3\n| StdInChI          = 1S/C23H26FN3O2/c24-13-7-2-8-14-27-16-19(18-11-5-6-12-21(18)27)23(29)26-20(22(25)28)15-17-9-3-1-4-10-17/h1,3-6,9-12,16,20H,2,7-8,13-15H2,(H2,25,28)(H,26,29)/t20-/m0/s1\n| StdInChIKey       = DDVANTXQCRMRFF-FQEVSTJZSA-N\n\n<!--Chemical data-->\n| C=23 | H=26 | N=3 | O=2 | F=1 \n| molecular_weight = \n}}\n\n'''PX-1''' (also known as '''5F-APP-PICA''' and '''SRF-30''') is an [[indole]]-based [[synthetic cannabinoid]] that has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/product/16201 | title=PX 1 | publisher=Cayman Chemical | access-date=15 July 2015}}</ref><ref>{{cite journal | vauthors = Presley BC, Logan BK, Jansen-Varnum SA | title = Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS | journal = Biomedical Chromatography | pages = e4786 | date = December 2019 | pmid = 31863591 | doi = 10.1002/bmc.4786 }}</ref>\n\n==Legality==\nSweden's public health agency suggested classifying PX-1 as hazardous substance on November 10, 2014.<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider f\u00f6resl\u00e5s bli klassade som h\u00e4lsofarlig vara | publisher=Folkh\u00e4lsomyndigheten | lang=sv | access-date=16 July 2015}}</ref>\n\nPX-1 is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.<ref>{{cite web | url=https://sso.agc.gov.sg/Act/MDA1973 | title=Misuse of Drugs Act | publisher=Singapore Government | date=30 April 2015 | access-date=24 July 2015}}</ref>\n\n== See also ==\n{{div col|colwidth=30em}}\n* [[5F-AB-PINACA]]\n* [[5F-ADB]]\n* [[5F-AMB]]\n* [[5F-APINACA]]\n* [[AB-FUBINACA]]\n* [[AB-CHFUPYCA]]\n* [[AB-CHMINACA]]\n* [[AB-PINACA]]\n* [[ADB-CHMINACA]]\n* [[ADB-FUBINACA]]\n* [[ADB-PINACA]]\n* [[ADBICA]]\n* [[APICA (synthetic cannabinoid drug)|APICA]]\n* [[APINACA]]\n* [[MDMB-CHMICA]]\n* [[PX-2]]\n* [[PX-3]]\n{{Div col end}}\n\n== References ==\n{{Reflist}}\n\n{{Cannabinoids}}\n{{Cannabinoidergics}}\n\n[[Category:Indoles]]\n[[Category:Cannabinoids]]\n[[Category:Designer drugs]]\n[[Category:Indolecarboxamides]]\n[[Category:Organofluorides]]\n\n{{cannabinoid-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "Added CAS", "url_page": "//en.wikipedia.org/wiki/PX-1"}
